Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Quest Life mulls...

    Quest Life mulls appeal against MHRA marketing suspension of drugs

    Written by savita thakur thakur Published On 2016-07-04T13:08:37+05:30  |  Updated On 4 July 2016 1:08 PM IST
    Quest Life mulls appeal against MHRA marketing suspension of drugs

    New Delhi : Chennai-based Quest Life Sciences said it is considering making an appeal against the UK drugs regulator MHRA's decision to suspend marketing of drugs which were approved based on the clinical studies done by it.


    Medicines and Healthcare products Regulatory Agency (MHRA) had issued a notice to Quest Life Sciences in June suspending of marketing authorisations of drugs that had won approval based on studies conducted by the contract research firm citing data integrity issues.


    "The company is also considering making an appeal in consultation with the affected sponsors," Quest Life Sciences President Yati Chug said in a emailed response to PTI.


    Five products and three companies are impacted by the MHRA action. All the studies were conducted in the year 2013-14 and one study conducted even earlier, he added.


    The company, however, said its "sponsors have shown confidence in Quest and are planning to conduct the study for MHRA very soon, to enable trigger a fresh audit by MHRA" without disclosing the name of the sponsors.


    Quest has received a successful closure of the inspection conducted by MHRA, recently, Chug added.


    The company has already implemented the corrective actions and even demonstrated to MHRA, he added.


    "However, MHRA were concerned with the conduct of the study in 2013-14 and chose to ignore the current GCP (Good clinical practice) standards, that had been implemented in Quest Life Sciences", Chug said.


    In the GCP inspection statement issued to the company by MHRA, said, "there was one critical finding identified during this inspection relating to 'Data Integrity'" and another "one major finding identified during this inspection relating to Archiving".


    The health regulator said though it acknowledged that preventative measures have been taken in an attempt to mitigate many of the issues identified during this inspection,"the responses often indicated that corrective actions could not be implemented as the systems and data reviewed during the inspection were historical".

    Data IntegrityGCPGood clinical practiceinspectionmarketing suspension of drugsMedicines and Healthcare Products Regulatory AgencyMHRAQuest LifeYati Chug
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok